NORDIC REGIONAL OFFICE
Gl. Kongevej 60,
Phone: +46 8 505 718 00 +46 8 505 718 00
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Grants to HCOs registered in Denmark
|Description||Recipient||Type of grant||Purpose||Timeframe||Amount funded DKK||Extent,
|Becoming and being a mother living with HIV – a multicenter longitudinal mixed methods study||Amager & Hvidovre Hospital, Dep. of Infectious Diseases, Copenhagen Univ. Hospital||Research Grant||Research study to investigate psychosocial outcomes and experiences of women living with HIV during pregnancy and early motherhood||Date; Jan 2021 – Dec 2022||427 500 DKK||N/A|
|Pathobiology guided therapy in immune-mediated inflammatory arthritis: study using ex vivo models||Aarhus University Hospital, Department of Biomedicine, Health||Research Grant||Research to provide novel insights into the molecular heterogeneity of immune-medicated arthritis and possibly identify markers for less impersonal treatment strategies||Date: Jan 2021 – Dec 2022||250 000 DKK||N/A|
|Updated estimate of hepatitis B and C prevalence||Odense University Hospital, Department of Infectious diseases||Estimate prevalence of HCV and HBV in DK||Date: Jan 2021 – Dec 2022||70 000 DKK||N/A|
Gilead has not provided support to any patient organization from Denmark in 2020. The information is correct at the time of writing (March 2021). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here
This page is intended for visitors outside of the United States.